Acumen Pharmaceuticals, Inc.
ABOS
$1.11
$0.098.82%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.55% | -7.00% | 79.78% | 79.84% | 37.11% |
| Total Receivables | 57.00% | 92.17% | -53.30% | -24.40% | 280.95% |
| Inventory | 62.24% | 113.43% | -95.48% | -91.09% | -50.75% |
| Prepaid Expenses | 6.32% | -16.86% | 171.43% | -26.08% | -27.03% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 185.46% | 239.13% | 256.49% | 81.98% | 36.07% |
| Total Current Assets | -27.70% | -5.02% | 78.49% | 77.62% | 36.76% |
|
|
|||||
| Total Current Assets | -27.70% | -5.02% | 78.49% | 77.62% | 36.76% |
| Net Property, Plant & Equipment | -32.60% | 208.00% | 160.61% | 115.60% | 86.30% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -16.52% | 7.41% | 21.74% | 90.77% | 200.66% |
| Total Assets | -22.94% | -6.77% | 62.86% | 60.20% | 57.75% |
|
|
|||||
| Total Accounts Payable | 309.57% | 71.95% | 107.85% | 304.07% | -15.91% |
| Total Accrued Expenses | 105.40% | 270.56% | 68.56% | -39.01% | 77.12% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -84.64% | 6,350.00% | 331.03% | 80.60% | 724.76% |
| Total Finance Division Other Current Liabilities | 8.49% | 148.15% | 645.00% | 411.70% | 61.83% |
| Total Other Current Liabilities | 8.49% | 148.15% | 645.00% | 411.70% | 61.83% |
| Total Current Liabilities | 112.84% | 226.57% | 80.13% | -3.50% | 66.04% |
|
|
|||||
| Total Current Liabilities | 112.84% | 226.57% | 80.13% | -3.50% | 66.04% |
| Long-Term Debt | -1.60% | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -47.18% | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 32.50% | 716.22% | 427.09% | 343.48% | 452.38% |
|
|
|||||
| Common Stock & APIC | 3.58% | 3.61% | 38.43% | 38.33% | 35.98% |
| Retained Earnings | -45.93% | -39.59% | -33.55% | -30.78% | -30.73% |
| Treasury Stock & Other | -115.38% | 201.77% | 74.61% | 72.52% | 141.54% |
| Total Common Equity | -31.90% | -22.50% | 44.46% | 46.32% | 41.42% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -31.90% | -22.50% | 44.46% | 46.32% | 41.42% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -31.90% | -22.50% | 44.46% | 46.32% | 41.42% |
|
|
|||||
